RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$1.86B
1-Year Return
33.9%
This Quarter Return
+7.41%
1 Year Return
+33.9%
3 Year Return
+119.1%
5 Year Return
+206.57%
10 Year Return
+613.71%
AUM
$1.98B
AUM Growth
+$70.6M
(+3.7%)
Cap. Flow
-$34.9M
Cap. Flow
% of AUM
-1.76%
Top 10 Holdings %
Top 10 Hldgs %
15.03%
Holding
324
New
29
Increased
50
Reduced
187
Closed
28
Top Buys
| 1 |
Fabrinet
FN
|
$18.9M |
| 2 |
Interface
TILE
|
$17.6M |
| 3 |
Methode Electronics
MEI
|
$17M |
| 4 |
Supernus Pharmaceuticals
SUPN
|
$12.1M |
| 5 |
Omnicell
OMCL
|
$10.3M |
Top Sells
| 1 |
FLTX
Fleetmatics Group PLC
FLTX
|
$21M |
| 2 |
COHR
Coherent Inc
COHR
|
$18M |
| 3 |
Protolabs
PRLB
|
$16.2M |
| 4 |
LOCK
LifeLock, Inc.
LOCK
|
$10.6M |
| 5 |
Tetra Tech
TTEK
|
$10.4M |
Sector Composition
| 1 | Healthcare | 19.12% |
| 2 | Industrials | 18.8% |
| 3 | Technology | 17.6% |
| 4 | Consumer Discretionary | 14.29% |
| 5 | Financials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Simulations Plus
SLP
$284M
| $778K | 0.04% |
80,646
+14,035
| +21% | +$135K |
|
252
iShares Micro-Cap ETF
IWC
$907M
| $758K | 0.04% |
8,829
+5,362
| +155% | +$460K |
|
253
Zimmer Biomet
ZBH
$20.8B
| $727K | 0.04% |
7,258
-1
| -0% | -$100 |
|
254
BioMarin Pharmaceuticals
BMRN
$10.9B
| $711K | 0.04% |
+8,588
| New | +$711K |
|
|
SRCL
255
DELISTED
Stericycle Inc
SRCL
| $684K | 0.03% |
+8,880
| New | +$684K |
|
256
L3Harris
LHX
$51.1B
| $652K | 0.03% |
6,366
| – | – |
|
257
Chevron
CVX
$318B
| $633K | 0.03% |
5,375
| – | – |
|
|
BBRG
258
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
| $611K | 0.03% |
160,668
-21,194
| -12% | -$80.6K |
|
259
Polaris
PII
$3.26B
| $571K | 0.03% |
+6,935
| New | +$571K |
|
260
ICU Medical
ICUI
$3.1B
| $533K | 0.03% |
3,615
+613
| +20% | +$90.4K |
|
261
Waste Management
WM
$90.6B
| $532K | 0.03% |
7,500
| – | – |
|
262
Merck
MRK
$210B
| $530K | 0.03% |
9,436
| – | – |
|
263
Berkshire Hathaway Class A
BRK.A
$1.09T
| $488K | 0.02% |
2
| – | – |
|
264
NOV
NOV
$4.96B
| $476K | 0.02% |
12,726
| – | – |
|
|
MNK
265
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $469K | 0.02% |
+9,406
| New | +$469K |
|
266
AT&T
T
$212B
| $455K | 0.02% |
14,163
| – | – |
|
267
Intel
INTC
$108B
| $454K | 0.02% |
12,525
-250
| -2% | -$9.06K |
|
|
WBA
268
DELISTED
Walgreens Boots Alliance
WBA
| $430K | 0.02% |
5,200
| – | – |
|
269
Vanda Pharmaceuticals
VNDA
$274M
| $429K | 0.02% |
26,885
+4,542
| +20% | +$72.5K |
|
|
NRCIB
270
DELISTED
National Research Corp Class B
NRCIB
| $405K | 0.02% |
9,714
+1,634
| +20% | +$68.1K |
|
271
3M
MMM
$82.8B
| $402K | 0.02% |
2,692
| – | – |
|
272
CoStar Group
CSGP
$37.7B
| $400K | 0.02% |
+21,230
| New | +$400K |
|
273
Teva Pharmaceuticals
TEVA
$21.2B
| $393K | 0.02% |
10,850
| – | – |
|
274
Moody's
MCO
$89.6B
| $370K | 0.02% |
3,929
| – | – |
|
275
Bristol-Myers Squibb
BMY
$95B
| $367K | 0.02% |
6,288
| – | – |
|